You are here: Industry Insights > Bayer

News List

Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases worldpharmanews
September 25, 2019
Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) announced the launch of a joint lab to research new drug candidates ...
ProBioGen Licenses GlymaxX® Technology to Bayer b3cnewswire
September 17, 2019
ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, announced the closing of a license agreement with Bayer AG for the GlymaxX® Technology.
Bayer's market cap now close to the total cost it paid for Monsanto fiercepharma
September 02, 2019
What does one of the worst corporate deals in modern history look like? In Bayer’s Monsanto takeover, it means the value of an entire company has gone poof.
Bayer to divest Animal Health unit for $7.6bn pharmaceutical-technology
August 22, 2019
Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco Animal Health for a total of $7.6bn, in a bid to focus on its core life sciences businesses.
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy biospectrumasia
August 15, 2019
Implied total company value of up to $1 billion, inclusive of 40.8 percent stake currently held by Bayer / Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year / BlueRo
Bayer wins ‘Best Employer in India 2019’ Award by Aon expresspharma
August 13, 2019
Aon, a global research consultancy, has awarded ‘Best Employer in India 2019’ Award to Bayer in an award ceremony held in Mumbai.
Bayer, Elanco could lock up animal health merger next week fiercepharma
August 11, 2019
When rumors emerged nearly a year ago that Bayer might be planning to exit the animal-health business, Eli Lilly spinoff Elanco was not at the top of any market-watcher’s list of potential buyers—especially not after it became clear that several private e
Bayer agrees to acquire biotech BlueRock for $1bn pharmaceutical-technology
August 09, 2019
German multinational pharmaceutical company Bayer has signed an agreement to acquire US-based biotechnology company BlueRock Therapeutics.
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy worldpharmanews
August 09, 2019
Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...
Bayer gets EU CHMP nod for precision oncology treatment larotrectinib biospectrumasia
August 04, 2019
Upon approval, larotrectinib would be the first therapy in Europe with a tumor-agnostic indication

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page